MedPath

MYLAN-LANSOPRAZOLE FDT

MYLAN-LANSOPRAZOLE FDT

Approved
DIN Number

02392402

Drug Class

Human

Market Date

N/A

Company
HC

Mylan Pharmaceuticals ULC

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02392402
AIG Number0127666002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A02BC03 LANSOPRAZOLE
Product Specifications
Dosage FormTablet (Delayed-Release)
Route of AdministrationOral
AHFS Classification56:28.36
Health Canada Classification

ACTIVE INGREDIENTS (1)

LANSOPRAZOLEActive
Strength: 15 MG
Monograph: LANSOPRAZOLE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.